Project Grant HT94252510981
- The $890,826 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support a study by the Denver Research Institute (DRI) to evaluate the comparative efficacy and implementation factors of Pain Reprocessing Therapy for veterans with chronic back pain. The four-year project, starting on September 30, 2024, will conduct research to assess the clinical effectiveness of this novel pain management approach and...
- The Denver Research Institute will receive $768,919 under a four-year Project Grant award from the Department of the Army Medical Command. The grant will fund research from September 2022 through September 2026 under the Military Medical Research and Development program (CFDA 12.420). The research aims to prevent suicide among survivors of military sexual violence by identifying critical risk periods and factors that attenuate or exacerbate suicide risk. The Military Medical Research and...
- The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
- The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
- The Veterans Medical Research Foundation of San Diego was awarded a $4,802,696 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2025, supports a four-year research project titled "A HYBRID I EVALUATION OF INTEGRATIVE HEALTH CARE FOR PTSD". The research aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical...
- The Department of Defense (DOD) is providing a $2,339,999 Project Grant award to the University of Colorado-Denver under the Military Medical Research and Development program (CFDA 12.420). The funding will support a randomized controlled trial to examine the efficacy of the Man Therapy platform in reducing problematic anger among military service members with and without a history of traumatic brain injury. The project will be conducted at the University of Colorado-Denver and is expected to...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,326,715 to the Boston VA Research Institute, Inc. (BVARI) to develop and conduct a preliminary evaluation of a self-directed, internet-based Cognitive Processing Therapy (CPT) intervention. The funding period is from September 1, 2024 to August 31, 2028. The key products and services to be delivered under this grant include: Developing the web-based CPT...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
- This federal Project Grant award, titled "COGNITIVE REHABILITATION FOR TREATMENT OF ANGER IN VETERANS WITH TBI AND PTSD," is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $2,411,921.00 award to Duke University, effective August 1, 2025 through July 31, 2029, will support advanced biomedical research to develop innovative solutions for treating anger issues in military veterans with traumatic brain injury (TBI) and...
The Defense Health Agency awarded a $2,463,887 Project Grant to the Denver Research Institute (DRI) to conduct a 4-year research project titled "Acceptance and Commitment Therapy for Moral Injury: A Transdiagnostic Intervention for Veterans and Service Members". This project is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military personnel and the broader public. The research aims to develop and evaluate an Acceptance and Commitment Therapy (ACT) intervention to address moral injury among veterans and service members. DRI, a non-profit research organization in Denver, Colorado, will leverage its expertise in clinical trials, data analysis, and scientific innovation to carry out this research effort, which has the potential to yield new treatment approaches for this critical health challenge faced by the military community.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.5m | 8/14/25 |